Keyphrases
Surabaya
96%
Children with HIV
80%
Apolipoprotein C3
80%
C3 Gene
80%
Polymorphism
80%
HIV Infection
80%
Indonesia
80%
Tuberculosis in children
80%
Risk Factors
80%
Tuberculosis
80%
Tuberculosis Contacts
80%
Schizoaffective Disorder
80%
Pediatric Pneumonia
80%
HIV Status
57%
BCG Scar
32%
Severe Malnutrition
32%
Anti-tuberculosis Drug-induced Hepatotoxicity
32%
25(OH)D3
26%
East Java Indonesia
26%
Duration of Therapy
20%
Process Plan
20%
Adolescent Patients
20%
Household Contacts
16%
Respirology
16%
Active Tuberculosis
16%
Significant Risk Factors
16%
Possible Risk Factors
16%
BCG Vaccine
16%
Tuberculosis Diagnosis
16%
Inpatient Ward
16%
Medical Records
16%
Outpatient Clinic
16%
Pediatric
16%
Mycobacterium Tuberculosis (M. tb)
16%
Nutritional Status
16%
Hospitalized Patients
16%
Vaccination Status
16%
Psychological Strategy
16%
Psychiatric Medication
16%
Psychiatric Counseling
16%
Reintroduction
16%
Serum 25-hydroxyvitamin D3
13%
Immunomodulatory Role
13%
Serum 25(OH)D3
13%
Homozygous mutant
10%
Absolute Value
10%
CD4%
10%
Highly Active Antiretroviral Therapy (HAART)
10%
Tolerability
10%
Metabolic Disorders
10%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Apolipoprotein C3
80%
Human Immunodeficiency Virus Infection
80%
Mycobacterium Bovis BCG
80%
Schizoaffective Psychosis
80%
Bronchiectasis
80%
Cholecalciferol
80%
Interleukin 8
80%
Placebo
40%
Vitamin D
40%
Metronidazole
26%
Tuberculosis
26%
Cross-Sectional Study
26%
Mycobacterium Tuberculosis
26%
Respiratory Tract Infection
13%
Calcifediol
13%
Randomized Controlled Trial
13%
Cytokine
13%
Erethism
10%
Observational Study
10%
Tolerability
10%
Medicine and Dentistry
Apolipoprotein C3
80%
Human Immunodeficiency Virus Infection
80%
Schizoaffective Disorder
80%
Bronchiectasis
80%
Miliary Tuberculosis
80%
Pediatric Pneumonia
80%
Diseases
40%
Treatment Duration
20%
Human Immunodeficiency Virus
20%
Public Health
20%
Lung Tuberculosis
20%
Coughing
20%
High Risk Population
20%
Patient Compliance
20%
Pediatrics
20%
Heredity
10%
Hypersensitivity
10%
Fisher Exact Test
10%
Restriction Fragment Length Polymorphism
10%
Observational Study
10%
Treatment Response
10%
DNA Polymorphism
10%
Highly Active Antiretroviral Therapy
10%
Metabolic Disorder
10%
